Medicines Security InstituteENGAGE MSI
Media & expert commentary

Independent perspective on
medicines security.

MSI welcomes serious media enquiries seeking evidence-led context on the systems, risks and policy choices shaping the availability and resilience of medicines.

Commentary availability

Context for consequential public questions.

At this stage, MSI offers expert commentary and background briefings. This page does not imply previous media coverage, endorsement or a standing spokesperson relationship.

  • Medicines shortages and national resilience
  • Pharmaceutical supply-chain dependencies
  • Secure medicines manufacturing and industrial strategy
  • AI, data and early-warning intelligence
  • Regulatory cooperation and geopolitical risk
  • Medicines-security governance and leadership
Please state the publication or programme, intended use and deadline. Availability cannot be guaranteed.
Please do not attribute comments to MSI until the terms of participation and attribution have been confirmed.

Forms use FormSubmit for email delivery. Privacy notice. If submission fails or a service activation prompt appears, email the executive office directly.

Media resources

Institute description, founder biography and downloadable brand assets.

Open the media kit →